Loading organizations...
Loading organizations...
Huarong Rongde Asset Management, based in Beijing, China, is an investment management firm specializing in fixed-income investments and broader asset management transactions for institutional and financial clients. Operating as a joint venture, it functions as a subsidiary of China Huarong Asset Management, which has since transitioned to China CITIC Financial Asset Management. The firm's operational framework includes strategic partnerships with international financial institutions such as Deutsche Bank AG and Clearwater Capital. Huarong Rongde actively supports significant deals and transactions, with its legal team facilitating approximately RMB 10 billion in deal value. Key figures associated with the organization include Yang Na, General Counsel and Head of Legal and Compliance, and Mr. Liu Zhengjun, Chairman of its former parent, China Huarong. The company was established in 2006.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 7, 2020 | Hinova Pharma | $147.6M Series C | — | DNV Capital, Infinity Group, Tigermed |